Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

SOPs for Analytical Method Development V 2.0

Analytical Method Development: Colorimetric Method Development – V 2.0

Posted on By

The purpose of this SOP is to outline the standardized approach for developing, optimizing, and validating colorimetric methods for the qualitative and quantitative determination of analytes in pharmaceutical substances. Colorimetric methods use specific reagents to develop color based on chemical reactions, which is then measured spectrophotometrically to infer concentration.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Limit Test for Chloride/Sulphate Development – V 2.0

Posted on By

This SOP defines the process for developing, standardizing, and validating limit tests for detecting chloride and sulphate impurities in APIs and excipients using visual comparison techniques with standard turbidity suspensions, in accordance with IP, USP, and Ph. Eur. guidelines.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Limit Test for Iron and Heavy Metals – V 2.0

Posted on By

This SOP outlines the procedure for developing and validating qualitative limit tests for the presence of iron and heavy metals in Active Pharmaceutical Ingredients (APIs), excipients, and pharmaceutical formulations. These tests use visual comparison with standard color or turbidity solutions and follow pharmacopeial methods.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: UV Spectrophotometric Method Development – V 2.0

Posted on By

The purpose of this SOP is to describe the standard procedure for developing, optimizing, and validating UV spectrophotometric methods for the quantitative analysis of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms using a UV-visible spectrophotometer.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: UV Spectrophotometric Method Development – V 2.0

Posted on By

This SOP describes the procedure for developing, optimizing, and validating UV spectrophotometric methods for quantitative analysis of pharmaceutical substances, including APIs, excipients, and finished dosage forms using UV-visible spectrophotometry.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Specific Gravity & Density Determination Method – V 2.0

Posted on By

The purpose of this SOP is to define the method for determining the specific gravity and density of liquid or semi-solid pharmaceutical substances using pycnometer, digital density meter, or hydrometer methods as per pharmacopoeial standards.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Total Organic Carbon (TOC) Method Development – V 2.0

Posted on By

This SOP defines the procedure for the development, optimization, and validation of analytical methods for Total Organic Carbon (TOC) determination using TOC analyzers. It applies to analysis of water samples, cleaning validation swabs, rinse samples, and other low-carbon pharmaceutical matrices.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Development of Assay Methods using Classical Techniques – V 2.0

Posted on By

This SOP describes the development, optimization, and validation of classical assay methods including titrimetric and gravimetric techniques for quantitative analysis of pharmaceutical raw materials, intermediates, and finished dosage forms.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Precipitation Reaction Based Method Development – V 2.0

Posted on By

This SOP describes the process of developing, optimizing, and validating analytical methods based on precipitation reactions for the quantification of specific analytes in raw materials, APIs, and pharmaceutical formulations.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: Complexometric Titration Method Development – V 2.0

Posted on By

The purpose of this SOP is to establish a standard procedure for the development, optimization, and validation of complexometric titration methods for the quantitative analysis of metal ions in pharmaceutical raw materials, active ingredients, and finished products.
Click to read the full article.

Analytical Method Development V 2.0

Posts pagination

Previous 1 … 5 6 7 … 38 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme